U.S. Department of Health and Human ServicesHHS NIH Logo Icon National Institutes of HealthNIH National Center for Advancing Translational SciencesNCATS
Assay Not Available
Not Available
Combination Screening Background
NCATS’s matrix combination screening platform can rapidly test the effect of different drug combinations on cellular, molecular or biochemical processes that are relevant to a disease of interest, including COVID-19. To better elucidate the dose-dependent activities in two-dimensional space, we have developed a state-of-the-art, high-throughput drug combination screening system in 6x6 or 10x10 dose matrix format using a highly integrated robotics system and custom data analysis software.


NCATS OpenData is licensed under a CC BY 4.0 license | 2020